Literature DB >> 2169493

Calcitonin, prostaglandin E2, and dibutyryl cyclic adenosine 3',5'-monophosphate disperse the specific microfilament structure in resorbing osteoclasts.

P T Lakkakorpi1, H K Väänänen.   

Abstract

Bone resorbing osteoclasts form a specific microfilament structure at the attachment area, in which vinculin and talin appear as a double-circle structure and F-actin fills the space between these circles. This distribution of microfilaments is associated with the resorption lacunae, and F-actin, vinculin, and talin zones correspond roughly to the edges of the lacunae. In the present work, we examined by immunofluorescence the effects of calcitonin (CT) and prostaglandin E2 (PGE2), inhibitors of osteoclastic activity, as well as dibutyryl cyclic AMP (Bt2cAMP) and cytochalasin B, on the microfilament organization in resorbing osteoclasts. CT, PGE2, and Bt2cAMP rapidly dispersed the specific microfilament structure in resorbing osteoclasts. All microfilament proteins studied (vinculin, talin, and F-actin) spread to the central areas of the original circles. The effect of CT was dose dependent. The effects of CT and PGE2 could be reversed, but recovery was slower after CT treatment than after PGE2 treatment. Cytochalasin B entirely destroyed the F-actin organization but only partially the vinculin organization. The results suggest that one structural change leading to the inactivation of the osteoclasts caused by CT and PGE2 is the disintegration of the microfilament structure at the attachment area of resorbing osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169493     DOI: 10.1177/38.10.2169493

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

1.  Resorption-cycle-dependent polarization of mRNAs for different subunits of V-ATPase in bone-resorbing osteoclasts.

Authors:  T Laitala-Leinonen; M L Howell; G E Dean; H K Väänänen
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

2.  Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.

Authors:  Ji-Won Lee; Ayumi Iwahashi; Shin-ichi Hasegawa; Takayuki Yonezawa; Won Bae Jeon; Byung-Yoon Cha; Kazuo Nagai; Je-Tae Woo
Journal:  J Nat Med       Date:  2011-06-09       Impact factor: 2.343

3.  PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.

Authors:  L T Duong; P T Lakkakorpi; I Nakamura; M Machwate; R M Nagy; G A Rodan
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

4.  Bone is not essential for osteoclast activation.

Authors:  Karen Fuller; Jade L Ross; Kinga A Szewczyk; Raymond Moss; Tim J Chambers
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

5.  The effects of bisphosphonates on the resorption cycle of isolated osteoclasts.

Authors:  K Selander; P Lehenkari; H K Väänänen
Journal:  Calcif Tissue Int       Date:  1994-11       Impact factor: 4.333

6.  Inhibitory effect of luteolin on osteoclast differentiation and function.

Authors:  Ji-Won Lee; Jae-Yong Ahn; Shin-Ichi Hasegawa; Byung-Yoon Cha; Takayuki Yonezawa; Kazuo Nagai; Hwa-Jeong Seo; Won-Bae Jeon; Je-Tae Woo
Journal:  Cytotechnology       Date:  2010-02-17       Impact factor: 2.058

7.  Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface.

Authors:  P T Lakkakorpi; M A Horton; M H Helfrich; E K Karhukorpi; H K Väänänen
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.